Table 2.
Discharged alive | Discharged deceased | p Value | |||
---|---|---|---|---|---|
n | %* | n | %* | ||
n | 203 | 70 | 87 | 30 | - |
Age, y† | 54.8 ± 1.0 | - | 63.0 ± 1.6 | - | <0.01 |
Hospital length of stay† | 41.2 ± 2.4 | - | 31.2 ± 3.0 | - | <0.01 |
ICU length of stay† | 20.1 ± 1.0 | - | 21.3 ± 2.2 | - | 0.90 |
White blood cell count† | 15.9 ± 0.9 | - | 16.2 ± 1.3 | - | 0.73 |
Race/Ethnicity | |||||
White | 176 | 86.7 | 75 | 86.2 | 0.91 |
African American | 22 | 10.8 | 7 | 8.0 | 0.47 |
Hispanic | 1 | 0.5 | 2 | 2.3 | 0.16 |
Other | 4 | 2.0 | 3 | 3.4 | 0.03 |
No. of infections treated during ICU admission | |||||
1 | 124 | 61.1 | 48 | 55.2 | 0.35 |
2 | 51 | 25.1 | 15 | 17.2 | 0.14 |
3 or more | 16 | 7.9 | 13 | 14.5 | <0.01 |
Total infections during ICU admission | 310 | - | 150 | - | - |
Comorbidities | |||||
Coronary artery disease | 66 | 32.5 | 33 | 37.9 | 0.39 |
Cerebrovascular disease | 17 | 8.4 | 10 | 11.5 | 0.41 |
Chronic renal disease | 21 | 10.3 | 7 | 8.0 | 0.54 |
Corticosteroids | 20 | 9.9 | 14 | 16.1 | 0.13 |
Liver disease | 29 | 14.3 | 18 | 20.7 | 0.18 |
Malignancy | 48 | 23.6 | 35 | 40.2 | <0.01 |
Peripheral vascular disease | 20 | 9.9 | 8 | 9.2 | 0.85 |
Pulmonary disease | 50 | 24.6 | 20 | 23.0 | 0.75 |
Autoimmune disorders | 6 | 3.0 | 3 | 3.4 | 0.83 |
Diabetes mellitus | 68 | 33.5 | 20 | 23.0 | 0.07 |
Other | 42 | 20.7 | 17 | 19.5 | 0.82 |
Interventions | |||||
Mechanical ventilation | 175 | 86.2 | 74 | 85.1 | 0.80 |
Total days intubated† | 14.9 ± 0.8 | - | 15.9 ± 1.0 | - | 0.35 |
Tracheostomy | 15 | 7.4 | 5 | 5.7 | 0.60 |
Transfusions | 142 | 70.0 | 68 | 78.2 | 0.07 |
Scoring† | |||||
GCS | 14.2 ± 0.2 | - | 13.8 ± 0.2 | - | 0.08 |
APACHE II | 18.5 ± 0.5 | - | 22.2 ± 0.7 | - | <0.01 |
MODS | 8 ± 0.3 | - | 8.3 ± 0.5 | - | 0.60 |
McCabe score | |||||
0 | 37 | 18.2 | 13 | 14.9 | 0.50 |
1 | 133 | 65.5 | 45 | 51.7 | 0.03 |
2 | 29 | 14.3 | 24 | 27.6 | <0.01 |
3 | 3 | 1.5 | 5 | 5.7 | 0.04 |
Percent based on total infected non-trauma population.
Expressed as mean ± Standard error of the mean.